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ABSTRACT
Purpose: The aim of this study was to investigate possible predictive factors related to anterior chamber fibrin formation after vitreoretinal
surgery in a large series of patients. Methods: The data of 185 eyes of 185 patients submitted to vitreoretinal surgery was reviewed. The
following variables were evaluated: the postoperatively presence of fibrin, age, diabetes mellitus, the vitrectomy system gauge (20, 23 or
25 gauge), the type of vitreous substitute, the influence of prior surgical procedures and the combination with cataract extraction. To
evaluate predictive factors for anterior chamber fibrin formation, univariate analysis was performed. A multivariate stepwise logistic
regression model was adjusted to investigate factors associated with fibrin formation (p<0.05). Results: Fibrinoid anterior chamber
reaction was found in 12 (6.4%) patients. For multivariate logistic regression analysis, balanced salt solution (BSS), the chance of fibrin
occurrence was 5 times greater (odds ratio 4.83, CI 95% 1.302 - 17.892; p=0.019), while combination with phacoemulsification increased
the chance of fibrin formation by 20 times (odds ratio 20, CI 95% 2.480 – 161.347; p=0.005). No significant difference was found
regarding other variables. Conclusion: Anterior chamber fibrin formation is an unwanted complication after vitreoretinal surgery.
Factors such as combined performance of phacoemulsification and the use of balanced salt solution as a vitreous substitute may predispose
the occurrence of this complication.
Keywords: Cataract/surgery; Fibrin; Phacoemulsification/adverse effects;  Vitrectomy/adverse effects; Tissue plasminogen activator;
Vitreoretinal surgery
RESUMO
Objetivo: Avaliar os possíveis fatores relacionados à formação de fibrina na câmara anterior após cirurgia vitreorretiniana em uma
grande série de casos. Métodos: Foi realizado um estudo retrospectivo, observacional, caso-controle, onde os dados de 185 olhos de
185 pacientes submetidos à cirurgia vitreorretiniana foram avaliados. Os seguintes dados foram analisados: presença ou não de
fibrina na câmara anterior na primeira semana de pós-operatório, idade, presença ou não de diabetes mellitus, calibre do sistema de
vitrectomia utilizado (20,23 ou 25 gauge), substituto vítreo, a influência de cirurgias oftalmológicas prévias e a realização de cirur-
gia de catarata combinada. Para avaliação dos fatores preditivos para formação de fibrina, a análise univariada foi realizada. O
modelo de regressão logística multivariada foi utilizado para investigar os fatores associados com a formação de fibrina (p<0,05).
Resultados: A presença de fibrina na câmara anterior foi encontrada em 12 (6,4%) pacientes. Pela análise de regressão logística
multivariada, o uso de solução salina balanceada (BSS) como substituto vítreo, a chance da presença de fibrina foi 5 vezes maior
(odds ratio 4,83, IC 95% 1,302 – 17,892; p=0,019), enquanto que a realização de cirurgia facoemulsificação combinada aumentou a
chance de formação de fibrina 20 vezes (odds ratio 20, IC 95% 2,480 – 161,347; p=0,005). Nenhuma diferença estatisticamente
significativa foi encontrada para as outras variáveis. Conclusão: A formação de fibrina na câmara é uma complicação indesejada
após cirurgia vitreorretiniana. Fatores como realização de cirurgia de facoemulsificação combinada e o uso de BSS como substituto
vítreo podem predispor a esta complicação.
Descritores: Catarata/cirurgia; Fibrina; Facoemulsificação/efeitos adversos; Vitrectomia/efeitos adversos; Ativador de
plasminogênio tecidual; Cirurgia vitreorretiniana
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Inflammatory reaction of the anterior segment associatedwith alterations of the blood-aqueous barrier are commonevents in the postoperative period of intraocular eye
surgery(1). These events are usually easily managed with the use
of topical anti-inflammatory medication for a few days or weeks.
Anterior chamber fibrin formation after intraocular surgeries, on
the other hand, is a rare and potentially serious complication that
may lead to visual loss from posterior capsule opacification, posteri-
or synechiae, intraocular lens decentration, intraocular hypertension
and pupillary seclusion(1,2). The incidence of anterior chamber fibrin
formation is estimated around 2% after cataract extraction and
intraocular lens implantation(3), but with the advent of modern small-
incision cataract surgery, it is probable that this incidence is much
lower nowadays. However, some special situations can lead to an
increased risk of developing anterior chamber fibrin formation after
intraocular surgeries, such as in children, diabetic patients, eyes with
uveitis, penetrating ocular trauma or complicated surgeries with
extensive manipulation, cataract surgery with posterior capsule
ruptured and combined surgical procedures(4-7).
The occurrence of anterior chamber fibrin reaction after
vitreoretinal surgery is an important complication, especially
because of posterior segment visualization impairment. Several
previous studies have evaluated the efficacy of recombinant
tissue plasminogen activator (t-PA) in case of anterior chamber
fibrinoid formation after vitreoretinal surgery(2,8-10). However,
none of them evaluated in detail the main factors involved in
the development of fibrin in anterior chamber after vitreoretinal
surgery. The aim of this study was therefore to investigate
possible predictive factors associated with the formation of fibrin
in the anterior chamber in patients submitted to vitreoretinal
surgery.
INTRODUCTION
METHODS
A retrospective, consecutive, observational study was
conducted between january 2009 and august 2010. The data
from all patients undergoing vitreoretinal surgery (pars plana
vitrectomy, associated or not intraocular lens implantation)
were reviewed. The following variables were evaluated:
presence of fibrin in anterior chamber within the first 3 days
after surgery, age, presence of diabetes, the gauge of the
vitrectomy system (20, 23 or 25), the type of vitreous substitute
(balanced salt solution – BSS, gas or silicone oil), the influence
of prior surgical procedures and the association with cataract
surgery at the time of vitreoretinal surgery. All patients included
in the study had complete medical records.
For statistical analysis, the comparison between groups
was performed using the Student t test, chi-square or Fischer’s
exact tests, for categorical variables and Student’s t test or
Mann-Whitney test for continuous variables. Using the variables
with   p<0.10 in the univariate model, a multivariate stepwise
logistic regression model was adjusted to investigate factors
associated with fibrin formation. A p value less than 0.05 was
considered statistically significant. In all regression analysis, the
presence of anterior chamber fibrin formation was considered
as the dependent variable, whereas patient’s age, presence of
diabetes, the vitrectomy system gauge, the type of vitreous
substitute and the association with cataract surgery were
considered as independent variables.
RESULTS
A total of 185 eyes of 185 patients submitted to vitreoretinal
surgery between january 2009 and august 2010 were included.
The mean age was 59.75 years ± 15.90 SD. One hundred and four
(56.21%) patients were male and 69 (37.29%) diabetic. In 86
(46.48%) a 20-gauge incision was used; in 87 (47%) a 23-gauge
and in 12 (6.48%), a 25-gauge incision was performed. In 50 (27%)
BSS was the vitreous substitute, in 48 (26%) intraocular gas (C3F8
or SF6) and in 87 (47%) silicone oil. Regarding prior surgical
procedures, 7 (3.78%) patients had previous vitrectomy followed
by silicone oil removal. Phacoemulsification was performed
combined with vitreorretinal surgery in 66 (35.7%) patients. The
two most frequent diagnoses were rhegmatogenous retinal
detachment (72 cases - 38.91%) and proliferative diabetic
retinopathy associated with vitreous hemorrhage with or without
tractional retinal detachment (48 cases - 25.9%). Table 1 shows
the distribution of patients according to the diagnosis.
The presence of fibrin in anterior chamber was found in 12
patients (6.5%) of 185 patients. The presence of intraocular fibrin
was graded as slight (several fibrin strands), moderate (compact
fibrin aggregates), or severe (fibrin membranes or clots)(3). In 8
patients fibrin was graded as moderate and in 4 as severe (table 2).
In all cases, the presence of fibrin was observed in the first
postoperative day. All patients with fibrinoid reaction underwent
25mcg/0.1mL of t-PA (Ophtalmos, São Paulo, Brazil) intracameral
injection under aseptic conditions. In all, there was a rapid absorption
of fibrin, with improvement of symptoms within the first 24 hours
(figure 1). No complications or adverse side effects possibly related
to t-PA were observed
Table 2 shows the clinical characteristics of 12 patients who
developed fibrinoid reaction. The mean age was 56.50 ± 15.41
and 57.05 ± 15.96 for the 173 patients without fibrinoid reaction.
No statistically significant difference between groups regarding
age or gender was found. Table 3 shows the comparison results
between the two groups. Among patients who had developed fibrin
in anterior chamber, BSS was used as vitreous substitute in 8 (6.7%)
(p=0.004), in 11 (91.7%) phacoemulsification combined with
vitreoretinal surgery was performed (p<0.001) and in 3(25%) the
silicone oil was removed, indicating a significant association with
these three variables (table 3 and 4).
Diagnosis n %
Macular holes  15  8.1
IOFB 3 1.6
DM, VH, tractional RD 48  25.9
Rhegmatogenous RD 72  38.9
Endophthalmitis 6  3.2
Misdirection glaucom 1  0.5
HV  10  5.4
ERM  19  10.3
Retained lens fragments 4  2.2
Vitreous opacities 7  3.8
Total  185 10
Table 1
Distribution of patients according to the diagnosis
in 185 patients submitted to vitreoretinal surgery
IOFB: intraocular foreing body; DM: diabetes mellitus; VH: vitreous
hemorrhage; RD: retinal detachment; ERM: epiretinal membrane
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Table 2
 Clinical characteristics of 12 patients submitted to vitreoretinal surgery and anterior chamber fibrin formation
Patient Age Sex Eye Diagnosis Surgical procedure Gauge Diabetes Vitreous
substitute
1
2
3
4
5
6
7
8
9
10
11
12
80
64
25
58
53
63
64
41
76
61
41
52
M
F
M
F
F
F
M
F
M
F
M
M
OS
OS
OS
OS
OD
OD
OS
OD
OD
OS
OS
OD
Rhegmatogenous RD
DM, VH, tractional RD
Rhegmatogenous RD
DM, VH, tractional RD
ERM
DM, VH, tractional RD
Rhegmatogenous RD
Rhegmatogenous RD
Retained lens fragments
ERM
Viteous opacities
Rhegmatogenous RD
Phacoemulsification + IOL + Silicone oil removal
Phacoemulsification + IOL + PPV
Phacoemulsification + IOL + Silicone oil removal
Phacoemulsification + IOL + PPV
Phacoemulsification + IOL + PPV
Phacoemulsification + IOL + PPV
Phacoemulsification + IOL + Silicone oil removal
Phacoemulsification + IOL + PPV
Phacoemulsification + IOL + PPV
Phacoemulsification + IOL + PPV
Phacoemulsification + IOL + PPV
PPV
20
20
20
20
25
23
20
23
23
23
23
23
No
No
No
Yes
No
Yes
No
No
No
No
No
No
BSS
Silicone oil
BSS
Gas
BSS
BSS
BSS
Gas
BSS
BSS
BSS
Gas
M: male; F: female; OD: right eye; OS: left eye; RD: retinal detachment; DM: diabetes mellitus; VH: vitreous hemorrhage; ERM: epiretinal membrane; IOL:
intraocular lens; PPV: pars plana vitrectomy; BSS: balanced salt solution
Figure 1: left - Patient with fibrin in anterior chamber in the first
post-operative of vitrectomy combined with phacoemulsification
with intraocular lens implantation; right - same patient three hours
after intracameral injection of 25mcg/0,1mL of t-PA; note the good
response to treatment, with improvement and better visualization
of the anterior segment (patient 5, table 2)
Table 3
Comparison between groups submitted to vitreoretininal
surgery according to the presence or absence of anterior
chamber fibrin formation
                      Without  fibrin        With fibrin        p-value
                          (n=173)            (n=12)
Age
Sex (M/F)
Vitreous substitutes
BSS
Gas
Silicone oil
Phacoemulsification
Gauge
20
23
25
Diabetes
Prior surgery
Silicone oil removal
59.98 ± 15.96
98/75
42 (24.3%)
42 (24.3%)
86 (46.48%)
55 (31.8%)
81 (46.8%)
81 (46.8%)
11 (6.4%)
67 (38.7%)
4 (2.3%)
56.50 ± 15.41
1
8 (66.7%)
3 (25%)
1 (8.3%)
11 (91.7%)
5 (41.7%)
6 (50.0%)
1 (8.3%)
2 (16.7%)
3 (25.0%)
0.465(*)
 0.654(**)
 0.004(***)
<0.0001(***)
<0.0001(***)
<0.0001(***)
0.925(**)
0.216(***)
0.006(***)
M: male; F: female; BSS: balanced salt solution; (*) Student t test;  (**) Chi-
square test;  (***) Fisher test; significant values are in italic (p<0.05)
Table 4
 Odds ratio and confidence intervals (CI) 95% of the
analyzed variables (univariate model)
 Variable        Odds ratio         CI 95% p-value
Age
Sex
   F
   M
BSS
   No
   Yes
Gas
   No
   Yes
Silicone oil
   No
   Yes
Phacoemulsification
   No
   Yes
Gauge
   20
   23
   25
Diabetes
  No
  Yes
Prior surgical procedure
Silicone oil removal
  No
  Yes
0.99
1
0.77
1
6.24
1
1.04
1
0.09
1
23.6
1
1.2
1.47
1
0.32
1
14.08
(0.95; 1.02)
-
(0.24; 2.47)
-
(1.79; 21.76)
-
(0.27;4.02)
-
(0.01;0.73)
-
(2.97; 187.39)
-
(0.35; 4.09)
(0.16; 13.80)
-
(0.07; 1.49)
(2.73;72.62)
0.464
-
0.654
-
0.004
-
0.771
-
0.013
-
0.003
-
0.771
0.735
-
0.145
0.002
M: male. F: female. BSS: balanced salt solution. Significant values are in
italic (p<0.05)
In order to determine whether the variables were risk or
protective factors for anterior chamber fibrin formation, the odds
ratio was estimated in the usual manner (table 4). The presence
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of fibrin was considered the variable dependent and the
phacoemulsification, the vitreous substitute (BSS, gas or silicone
oil), the gauge of vitrectomy system used (20, 23 or 25), the
silicone oil removal and the presence of diabetes mellitus were
considered independent variables. It was found that use of BSS,
the silicone oil removal and the concomitant performances of
phacoemulsification were associated with the presence of fibrin.
The patients in which BSS was used, the chance of fibrin formation
was six times higher than those in which BSS was not used (odds
ratio 6.24, CI 95% 1.79 - 21.76; p=0.004). In patients submitted
to silicone oil removal, the chance of fibrin formation was 14
times higher (odds ratio 14.08, CI 95% 2.73 – 72.62; p=0.002).
In patients who underwent phacoemulsification combined
vitreoretinal surgery, the chance of fibrin formation was 24 ti-
mes higher than patients undergoing vitreoretinal surgery without
cataract extraction (odds ratio 23.6, CI 95% 2.97 - 187.39;
p=0.003) (Table 4).
For multivariate logistic regression analysis, variables with
p<0.10 in univariate models were selected. Therefore, the use of
BSS, silicone oil removal and phacoemulsification were chosen.
For the multivariated model, logistic regression analysis found
that only BSS and phacoemulsification were associated with the
fibrin formation (Table 5), while the silicone oil removal were
not (p=0.17). In patients that used BSS, the chance of fibrin
occurrence was 5 times greater (odds ratio 4.83, CI 95% 1.302 -
17.892; p=0.019), while in patients who underwent
phacoemulsification, the chance of occurrence of fibrin was 20
times higher (odds ratio 20, CI 95% 2.480 – 161.347; p=0.005).
Table 5
Odds ratio and confidence intervals 95% of the
analyzed variables (multivariate model)
    Variable                   Odds ratio     CI 95%             p-value
                                        adjusted
BSS
   No
   Yes
Phacoemulsification
   No
   Yes
1
4.83
1
20
-
(1.30; 17.89)
-
(2.48; 161.35)
-
0.019
-
0.005
CI: confidence intervals; M: male; F: female; BSS: salt balanced
solution; Significant values are in italic (p<0.05)
DISCUSSION
The importance of this present study was to assess the
incidence of anterior chamber fibrin formation in patients
submitted to vitreoretinal surgery and also which predictive
factors were involved. Only a few previous studies evaluated
the incidence of fibrinoid reaction after intraocular surgery.
Heiligenhaus et al.(1) investigated in a multicenter, prospective,
randomized study the effect of intracameral t-PA in patients with
severe fibrinoid reaction after cataract surgery. These authors
included 86 patients in this study, corresponding, approximately,
to 2% of all cataracts performed during all period of the study, in
the six participating centers. This work was conducted from 1993
to 1994, and included patients who underwent both
phacoemulsification and extracapsular cataract extraction.
Although we did not find recent studies assessing the incidence
of anterior chamber fibrin formation after modern cataract
surgery using phacoemulsification, we believe the incidence is
lower than that determined by those authors, due to major
advances and improvements in surgical technique, intraocular
lens and viscoelastic achieved in recent years.
The association between vitreoretinal surgery and fibrin
formation was first described by Sebestyen(5). This author
evaluated 280 consecutive cases of vitrectomy in diabetic patients
and in 15 eyes (5.35%) described the presence of fibrinoid
reaction in the vitreous chamber, between the surface of the re-
tina and the posterior iris plane. This author found that the
combination of surgery to remove the lens, performing retinopexy
with scleral buckling and the presence of retinal detachment
preoperatively, could predispose to the occurrence of this
complication. Performing multiple combined procedures at the
same surgery would presumably lead to an increased vascular
permeability, which results in a gelatinous material, resembling
fibrin in the vitreous of diabetic patients.
In the present study, the incidence of fibrin formation
(6%), was similar to that found by Sebestyen (5.35%)(5). But it
was surprising that, contrary to what suggested by this author,
the presence of diabetes mellitus was not associated with an
increased risk for fibrin formation. This can be explained, at
least in part, by the fact that the majority of diabetic patients
submitted to vitrectomy procedure were cases in severe stages,
with a presence of vitreous hemorrhage, fibro-vascular
proliferation and tractional retinal detachment, requiring the
use silicone oil, in most cases. The silicone oil may acts as a
mechanical barrier, preventing the free diffusion and circulation,
in the vitreous chamber, of factors that can lead to fibrinoid
anterior chamber reaction. In accordance with the hypothesis,
in the present study, only one patient in which silicone oil was
used developed fibrin. It should be pointed the strong
association of fibrinoid reaction and the use of BSS as a vitreous
substitute (odds ratio 6.24). Although the exact explanation is
still unknown, we believe that the higher incidence of fibrin
formation associated with the use of BSS compared to gas or
silicone oil may be related to the diffusion of inflammatory cells
between the anterior and posterior chambers of the eye. It is
possible that the presence of BSS in the vitreous chamber has
facilitated the diffusion of fibrin-forming substances between
the anterior and posterior segments. On the other hand, gas or
silicone oil in the vitreous may have functioned as a more
effective barrier to the diffusion of inflammatory agents and,
therefore, accounted for the smaller incidence with those
vitreous substitutes.
Of all the factors related to fibrin formation in the anterior
chamber, the one that suggested the highest risk was the
performance of phacoemulsification combined with vitreoretinal
surgery (odds ratio 23.6). Williams et al.(8) in 1988, reported the
presence of fibrinoid reaction after extensive vitrectomy in 3
aphakic eyes. Jaffe et al.(2) described the intense presence of
fibrin in anterior chamber after vitrectomy in seven patients, also
all aphakic. Therefore, the lens extraction combined with poste-
rior vitrectomy seems to be a risk factor for development of fibrin
in anterior chamber. In this study, 11 of 12 eyes presented with
fibrinoid reaction had been submitted to phacoemulsification with
intraocular lens implantation associated with posterior vitrectomy.
Therefore, the association between anterior chamber fibrin
formation, posterior vitrectomy and phacoemulsification seems
to be a reasonable assumption.
This association can be justified, at least in part, by surgical
manipulation of the anterior segment during
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phacoemulsification, which usually precedes the vitrectomy,
promoting a change in the blood-aqueous barrier, increasing
vascular permeability, platelet activation, platelet derived
growth factor secretion and increased levels of fibrinogen, which
finally, will be converted into fibrin(3-5). The case 12 (table 2)
underwent vitrectomy for rhegmatogenous retinal detachment,
and presented with fibrin in anterior chamber, but without the
concomitant performance of phacoemulsification. This patient
was already pseudophakic and had posterior capsule rupture.
During the intraoperative period, in this case, it was necessary
to approach the anterior segment because of the migration of
gas to anterior chamber. The manipulation of the anterior
segment could justify, in this case, the breaking of the blood-
aqueous and fibrin formation.
In fact, all 185 study patients, who underwent to vitreoretinal
surgery, no phakic patients showed fibrin in the anterior chamber.
Therefore, it seems that the absence of surgical manipulation of
anterior segment and the preservation of lens, may act as protective
factors for the occurrence of anterior chamber fibrin formation in
patients submitted to vitreoretinal surgery.
Prior surgical procedures could be a risk factor for fibrin
formation, since we can assume that these cases are more
complex and also because they have been previously
surgically manipulated, thus these factors can contribute to
fibrin formation. This is the case of patients who underwent
silicone oil removal. In the present study, 7 eyes had silicone
oil removal at the time of surgery and three of them
developed fibrin formation. When we calculated the odds
ratio in a univariate model it was 14.08 (CI 95%; 2,73 - 72,62;
p=0.002) suggesting that it might be an important factor.
However, 6 of the 7 patients had also been submitted to
simultaneous phacoemulsification including all three that
developed fibrin formation. Therefore when we pursued in
the statistical analysis using multivariate logistic regression
analysis the odds ratio for silicone oil extraction dropped to
3.64 (not significant, p=0.17). The fibrin formation in these
cases was therefore probably related to both the
phacoemulsification and use of BSS and not directly related
to silicone oil removal.
All patients who developed fibrin in anterior chamber were
treated with 25mcg/0.1mL of t-PA intracameral, with complete
resolution and no relevant side effects. In fact, several previous
studies, clinical and experimental, have shown that t-PA is a safe
and effective form of treatment for fibrinoid reaction, both in
patients undergoing phacoemulsification and vitreoretinal
surgery(2,8,9,11-17).
In accordance with the present study, the anterior chamber
fibrin formation is a possible and unwanted complication after
vitreoretinal surgery. Factors such as combined performance of
phacoemulsification and the use of balanced salt solution as a
vitreous substitute may predispose the occurrence of this
complication. Surgeons should be warned about this complication
and its related factors for it may have great influence in patients’
visual outcome.
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